HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury.

Abstract
Nuclear factor-kappaB (NF-kappaB) plays a central role in myocardial ischemia-reperfusion (MI/R) injury. The inhibitory protein IkappaBalpha prevents its activation. We investigated the effects of adeno-associated viral vector-mediated IkappaBalpha gene transfer in MI/R injury. Male C57BL/6 mice were randomized to receive a recombinant adeno-associated virus (rAAV) encoding the gene for the NF-kappaB inhibitory protein IkappaBalpha (rAAV- IkappaBalpha) or the beta-galactosidase gene (a control and inert gene; rAAV-LacZ), both at a dose of 10(11) copies. Four weeks later anesthetized animals were subjected to total occlusion (45 minutes) of the left main coronary artery followed by 5 hours of reperfusion. MI/R produced a wide infarct size (IF/area-at-risk = 56 +/- 8%; IF/left ventricle = 44 +/- 5%) and tissue neutrophil infiltration, studied by means of elastase activity (area-at-risk = 2.5 +/- 0.4 micro g/gm tissue; infarct area = 2.9 +/- 0.6 micro g/gm tissue). Furthermore MI/R caused peak message for intercellular adhesion molecule-1 (ICAM-1) in the area-at-risk at 3 hours of reperfusion (1.2 +/- 0.4 relative amount of cardiac ICAM-1 mRNA). NF-kappaB activation was evident at 0.5 hours of reperfusion and reached its maximum increase at 2 hours of reperfusion. rAAV-IkappaBalpha injection reduced infarct size (IF/area-at-risk = 19 +/- 3%; IF/left ventricle = 10 +/- 2%; p < 0.001), blocked NF-kappaB activation, diminished cardiac ICAM-1 expression (0.4 +/- 0.02 relative amount of cardiac ICAM-1 mRNA; p < 0.001), and blunted leukocyte accumulation (area-at-risk = 0.6 +/- 0.05 micro g/gm tissue; infarct area = 0.4 +/- 0.02 micro g/gm tissue; p < 0.001). Our data indicate that rAAV-IkappaBalpha may be useful for MI/R gene therapy.
AuthorsFrancesco Squadrito, Barbara Deodato, Giovanni Squadrito, Paolo Seminara, Maria Passaniti, Francesco S Venuti, Mauro Giacca, Letteria Minutoli, Elena B Adamo, Maria Bellomo, Rolando Marini, Mariarosaria Galeano, Herbert Marini, Domenica Altavilla
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 83 Issue 8 Pg. 1097-104 (Aug 2003) ISSN: 0023-6837 [Print] United States
PMID12920239 (Publication Type: Journal Article)
Chemical References
  • DNA Primers
  • I-kappa B Proteins
  • NF-kappa B
  • Nfkbia protein, mouse
  • RNA, Messenger
  • Intercellular Adhesion Molecule-1
  • NF-KappaB Inhibitor alpha
  • beta-Galactosidase
  • Pancreatic Elastase
Topics
  • Adenoviridae (genetics)
  • Animals
  • Blotting, Western
  • DNA Primers (chemistry)
  • Gene Transfer Techniques
  • Genetic Therapy
  • Heart Ventricles (metabolism, pathology)
  • I-kappa B Proteins (genetics)
  • Intercellular Adhesion Molecule-1 (genetics, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Infarction (genetics, pathology, prevention & control)
  • Myocardial Reperfusion Injury
  • NF-KappaB Inhibitor alpha
  • NF-kappa B (metabolism)
  • Pancreatic Elastase (metabolism)
  • RNA, Messenger (metabolism)
  • Transduction, Genetic (methods)
  • beta-Galactosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: